ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,975Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 3734

$1.6M Total Retail Price of All Prescriptions

Rank: 13 out of 3734

713 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 713 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 713 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 21,840 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 1,042 1,021 1 10
SIMVASTATIN 1,032 800 2 1
LEVOTHYROXINE SODIUM 923 778 3 2
FUROSEMIDE 888 797 4 7
METOPROLOL TARTRATE 852 778 5 6
HYDROCODONE-ACETAMINOPHEN 735 439 S3 6 12
CITALOPRAM HBR 498 431 7 16
AMLODIPINE BESYLATE 478 392 8 5
LISINOPRIL 467 347 9 3
OMEPRAZOLE 411 274 10 4
KLOR-CON M20 410 375 11 48
POLYETHYLENE GLYCOL 3350 401 336 12 53
METOPROLOL SUCCINATE 400 335 13 14
MIRTAZAPINE 387 370 14 45
METFORMIN HCL 386 315 15 8
DONEPEZIL HCL 357 346 16 25
ALBUTEROL SULFATE 349 317 17 128
GABAPENTIN 347 261 18 17
TAMSULOSIN HCL 274 239 19 29
TRAMADOL HCL 248 207 20 20
CLOPIDOGREL 246 235 21 23
GLIMEPIRIDE 243 172 22 37
SERTRALINE HCL 240 173 23 18
NAMENDA 233 233 24 44
DIGOXIN 225 211 25 43
QUETIAPINE FUMARATE 205 198 26 82
ATORVASTATIN CALCIUM 204 162 27 11
ALENDRONATE SODIUM 198 196 28 26
ADVAIR DISKUS 187 172 29 35
CARVEDILOL 185 163 30 30
FENTANYL 180 107 S2 31 65
PREDNISONE 178 174 32 42
LANTUS 177 161 33 54
CYMBALTA 173 130 34 67
POTASSIUM CHLORIDE 172 153 35 19
ESCITALOPRAM OXALATE 171 171 36 68
HYDROCHLOROTHIAZIDE 168 148 37 9
PLAVIX 166 159 38 39
JANUVIA 162 134 39 50
ATENOLOL 161 151 40 13
CARBIDOPA-LEVODOPA 156 144 41 92
RISPERIDONE 153 111 42 62
NOVOLOG 143 122 43 112
ZOLPIDEM TARTRATE 139 98 44 24
AMIODARONE HCL 139 137 44 203
PRAVASTATIN SODIUM 132 124 46 15
IPRATROPIUM-ALBUTEROL 128 112 47 98
ALLOPURINOL 126 116 48 33
METOCLOPRAMIDE HCL 122 84 49 158
DIOVAN 122 105 49 31
EXELON 121 121 51 150
GLYBURIDE 117 95 R 52 64
SPIRIVA 115 115 53 40
LOSARTAN POTASSIUM 114 111 54 21
PANTOPRAZOLE SODIUM 108 83 55 22
VERAPAMIL ER 107 91 56 96
RANITIDINE HCL 106 77 57 32
SILVER SULFADIAZINE 103 89 58 366
SPIRONOLACTONE 102 97 59 80
SEROQUEL 101 95 60 161
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 82 61 117
OXYCODONE HCL 98 30 S2 62 58
ONDANSETRON HCL 95 0 63 262
ISOSORBIDE MONONITRATE ER 94 94 64 34
FAMOTIDINE 92 84 65 60
LIDODERM 90 80 66 170
LEVETIRACETAM 88 69 67 105
ENALAPRIL MALEATE 88 76 67 63
BENZTROPINE MESYLATE 88 56 R 67 173
AMLODIPINE BESYLATE-BENAZEPRIL 86 76 70 56
MOMETASONE FUROATE 85 74 71 275
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 65 71 27
TAMIFLU 85 76 71 302
NEXIUM 85 33 71 36
CIPROFLOXACIN HCL 84 76 75 77
NITROFURANTOIN MONO-MACRO 84 82 75 196
HYDRALAZINE HCL 84 83 75 111
OXYCONTIN 83 27 S2 78 121
SINGULAIR 82 34 79 95
BUSPIRONE HCL 82 81 79 129
BUDESONIDE 81 77 81 231
ZETIA 81 63 81 55
CLOTRIMAZOLE-BETAMETHASONE 80 72 83 135
KLOR-CON M10 80 64 83 115
VENTOLIN HFA 80 14 83 70
LEVOFLOXACIN 79 71 86 116
PAROXETINE HCL 77 34 87 59
PHENYTOIN SODIUM EXTENDED 76 49 88 149
CARBAMAZEPINE 74 42 89 172
LATANOPROST 74 74 89 197
VENLAFAXINE HCL ER 72 61 91 84
CEPHALEXIN 72 65 91 120
FLUTICASONE PROPIONATE 71 41 93 46
CRESTOR 71 71 93 28
DIVALPROEX SODIUM 71 58 93 99
RAMIPRIL 70 70 96 91
OXYCODONE-ACETAMINOPHEN 70 45 S2 96 51
DETROL LA 69 61 98 153
TRAZODONE HCL 67 25 99 49
VERAPAMIL HCL 67 43 99 507
AVELOX 66 48 101 366
MELOXICAM 66 57 101 52
DICLOFENAC SODIUM 66 38 101 127
ABILIFY 66 44 101 159
OXYBUTYNIN CHLORIDE ER 63 40 105 141
DOXAZOSIN MESYLATE 62 35 106 100
PHENYTOIN 60 25 107 288
AMOXICILLIN 59 57 108 108
OXYBUTYNIN CHLORIDE 57 54 109 151
HUMALOG 56 54 110 146
OLANZAPINE 55 34 111 106
CELEBREX 55 39 111 69
NOVOLIN 70-30 54 51 113 252
QUINAPRIL HCL 53 41 114 74
ROPINIROLE HCL 53 49 114 118
TRAVATAN Z 52 52 116 278
LITHIUM CARBONATE 52 24 116 279
CEFUROXIME 52 42 116 168
OXCARBAZEPINE 51 0 119 329
GLIPIZIDE 51 43 119 57
MORPHINE SULFATE ER 50 0 S2 121 104
LYRICA 50 18 121 124
PROAIR HFA 50 38 121 83
FINASTERIDE 50 50 121 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.